The personal users segment by end user is estimated to lead the market growth during the forecast period.

According to a new market research study of “North America Mobile ECG Devices Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Type, Modality, End User and Country.” The North America mobile ECG devices market is expected to reach US$ 994.14 million by 2028 from US$ 712.04 million in 2021; it is estimated to grow at a CAGR of 4.9% from 2021 to 2028. The report highlights trends prevailing in the North America mobile ECG devices market and the factors driving market along with those that act as hindrances.

ECG monitoring is an essential part of the healthcare services for older adults due to which the elderly population is a primary target of mobile ECG monitoring system providers. According to the US Census Bureau, the number of Americans with age 65 and above is anticipated to double from 46 million in 2016 to more than 98 million by 2060, and the share of elderly population in the total population will increase to ~24% from ~15% during this period. With a significant rise in the number of people aged 65 and above, the number of people suffering from CVDs is likely to increase in the coming years as the prevalence of these diseases is associated with aging due to weak immunity among these people. Thus, the demand for mobile and wireless devices, and other technological advancements to ensure improved CVD prevention and control is likely to rise in the future. Therefore, the geriatric population is also prone to arrhythmia, among other aging-related diseases, which is likely to boost the demand for mobile ECG devices for diagnosis and treatment during the forecast period. The ECG systems are the most effective instruments for detecting arrhythmias (abnormal heart rhythm), coronary artery disease, atrial fibrillation, previous heart attack, and other conditions. According to the World Health Organization (WHO), CVDs are the leading cause of death worldwide, which cause 17.9 million deaths in the world each year; moreover, 30 million people suffer from stroke every year. According to the WHO factsheets, ~17.7 million people died due to CVDs in 2017, of which ~7.4 million mortalities were due to coronary heart disease and 6.7 million were due to stroke. Therefore, the rise in the incidence of cardiovascular diseases and other heart-related conditions is driving mobile ECG device market growth.

The onset of COVID-19 in North America led to the overburdening of healthcare systems, and the delivery of medical care to all patients became a critical challenge in the region. Moreover, a sudden surge in number of infections led to the shortage of emergency health supplies such as ventilators, beds, and oxygen cylinders. To manage the outbreak, governments took preventive measures including total lockdowns and social distancing policies. As the COVID-19 pandemic continues to unfold, medical device companies started facing difficulties in managing their operations. Many companies offering products for cardiac monitoring have their business operations in the US, and the pandemic adversely affected these businesses due to the temporary shutdown of facilities and disturbed operations of suppliers or customers. Moreover, since March 2020, US healthcare authorities framed policies about elective cardiac surgeries. To free up hospital beds for COVID patients, hospitals had to postpone or cancel their fewer essential operations. However, demand for vital sign monitoring devices in the region had substantial impact on the adoption of ECG devices.

The North America mobile ECG devices market, based on type, has been segmented into monitoring ECG systems and diagnostic ECG systems. The North America mobile ECG devices market, based on application, is segmented into handheld, band, pen, and others. The North America mobile ECG devices market, based on end user, is segmented into personal users, hospitals and clinics, and ambulatory services. Geographically, the North America mobile ECG devices market is sub-segmented into U.S, Canada and Mexico.

CardioComm Solutions Inc., Koninklijke Philips N.V., Bittium Biosignals LTD. (Subsidiary of Bittium Corporation), Medtronic, AliveCor, Inc, Nihon Kohden Corporation, EB Neuro S.P.A and Preventice Solutions are among the leading companies operating in the North America mobile ECG devices market.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com